Published :
Report ID:
Pages :
Format :
The global Cardiopulmonary Stress Tester market will grow from USD 3.7 billion to USD 6.7 billion from 2021 to 2026, at a CAGR of 5.0%.
Cardiopulmonary Stress Tester Market Overview:
Cardiopulmonary exercise testing (CPET) has become an important clinical tool for assessing exercise capacity and predicting outcome in patients with heart failure and other cardiac diseases.
CPET provides an assessment of combined exercise responses involving the pulmonary, cardiovascular, and skeletal muscular systems that are not adequately reflected by measures of individual organ system function.
CPET involves the measurement of respiratory oxygen uptake (Vo2), carbon dioxide production (Vco2), and ventilatory measures during symptom-limited exercise testing.
Cardiopulmonary exercise testing is a combination of traditional exercise testing procedures (eg, electrocardiogram, blood pressure) with ventilation-expiratory analysis (eg, oxygen consumption, carbon dioxide production, and minute ventilation).
Cardiopulmonary Stress Tester market size, estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Cardiopulmonary Stress Tester market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and the Russian-Ukraine war.
Major Market Segments Covered in Cardiopulmonary Stress Tester Industry Research:
Market Key Players:
Cardionics, MES, Ganshorn Medizin Electronic, CORTEX Biophysik, Medset Medizintechnik, Custo med, Piston, Medisoft Group, MEC - Medical Electronic Construction, MGC Diagnostics, SCHILLER, THOR, And Others.
By Type:
By Application:
By Region:
North America represents the largest market share as healthcare professionals are well aware of the advantages of CPST in the region. Asia Pacific is expected to witness high growth owing to the high prevalence of cardiovascular and pulmonary disease patients in the region. Severe air pollution has led to an exponential increase in respiratory and cardiovascular diseases worldwide.
Significant Market Dynamics:
Growth Factors
Growth factors for the global cardiopulmonary stress testers market include increasing prevalence of heart disease, technological advancements in the field of cardiology, and rising demand for minimally invasive procedures. Furthermore, the growing geriatric population is also expected to drive the market over the forecast period.
Cardiopulmonary Stress Tester Market report scope:
Report Attributes |
Details |
Growth Rate |
CAGR of 5.0% from 2022 to 2030. |
By Type |
Transportable Type, Mesa Type, Wearable Type, Other, |
By Application |
Hospital, Clinic, Physical Examination Center |
By Companies |
Cardionics, MES, Ganshorn Medizin Electronic, CORTEX Biophysik, Medset Medizintechnik, Custo med, Piston, Medisoft Group, MEC - Medical Electronic Construction, MGC Diagnostics, SCHILLER, THOR |
Regions and Countries Covered |
|
Base Year |
2022 |
Historical Year |
2017 to 2022 |
Forecast Year |
2023 to 2030 |
Key Takeaways from this Cardiopulmonary Stress Tester Report
Frequently Asked Questions-
What is the CAGR of Cardiopulmonary Stress Tester market?
The Cardiopulmonary Stress Tester Market is growing at a CAGR of 5.0% During Forecast Period.
What are the key types of Cardiopulmonary Stress Tester market?
Transportable Type, Mesa Type, Wearable Type, Other,
What are the key applications of Cardiopulmonary Stress Tester market?
Hospital, Clinic, Physical Examination Center
Who are the key players in Cardiopulmonary Stress Tester market?
Cardionics, MES, Ganshorn Medizin Electronic, CORTEX Biophysik, Medset Medizintechnik, Custo med, Piston, Medisoft Group, MEC - Medical Electronic Construction, MGC Diagnostics, SCHILLER, THOR, And others.